4.4 Article

An Exposure-Response Analysis of the Clinical Efficacy of Ponesimod in a Randomized Phase II Study in Patients with Multiple Sclerosis

Related references

Note: Only part of the references are listed.
Article Chemistry, Multidisciplinary

Modeling the Effect of the Selective S1P(1) Receptor Modulator Ponesimod on Subsets of Blood Lymphocytes

Dominik Lott et al.

PHARMACEUTICAL RESEARCH (2017)

Article Clinical Neurology

MRI in the assessment and monitoring of multiple sclerosis: an update on best practice

Ulrike W. Kaunzner et al.

THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2017)

Review Radiology, Nuclear Medicine & Medical Imaging

Imaging in multiple sclerosis: A new spin on lesions

Rayan Bou Fakhredin et al.

JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY (2016)

Article Clinical Neurology

Oral ponesimod in relapsing-remitting multiple sclerosis: a randomised phase II trial

Tomas Olsson et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2014)

Review Clinical Neurology

Defining the clinical course of multiple sclerosis The 2013 revisions

Fred D. Lublin et al.

NEUROLOGY (2014)

Article Pharmacology & Pharmacy

Pharmacokinetics and pharmacodynamics of ponesimod, a selective S1P1 receptor modulator, in the first-in-human study

Patrick Brossard et al.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2013)

Review Clinical Neurology

Sex and gender issues in multiple sclerosis

Hanne F. Harbo et al.

THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2013)

Review Immunology

Sphingosine-1-Phosphate and Lymphocyte Egress from Lymphoid Organs

Jason G. Cyster et al.

ANNUAL REVIEW OF IMMUNOLOGY, VOL 30 (2012)

Article Clinical Neurology

Diagnostic Criteria for Multiple Sclerosis: 2010 Revisions to the McDonald Criteria

Chris H. Polman et al.

ANNALS OF NEUROLOGY (2011)

Article Clinical Neurology

Age-related gadolinium-enhancement of MRI brain lesions in multiple sclerosis

C Tortorella et al.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2005)

Article Mathematical & Computational Biology

A method to assess the proportion of treatment effect explained by a surrogate endpoint

ZQ Li et al.

STATISTICS IN MEDICINE (2001)